Conditional risk factors for atherosclerosis
- PMID: 15704777
- DOI: 10.4065/80.2.219
Conditional risk factors for atherosclerosis
Abstract
Although most patients who experience a coronary heart disease (CHD) event have one or more of the conventional risk factors for atherosclerosis, so do many people who have not yet experienced such an event. Therefore, predictive models based on conventional risk factors have a lower than desired accuracy, providing a stimulus to search for new tools to refine CHD risk prediction. In particular, there is intense interest in evaluating circulating biomarkers related to the atherosclerotic process that might add to our ability to better predict CHD risk. One such group of biomarkers was termed conditional risk factors in an American Heart Association/American College of Cardiology statement in 1999. The conditional risk factors include homocysteine, fibrinogen, lipoprotein(a), low-density lipoprotein particle size, and C-reactive protein. This review updates the conditional risk factors. The main focus is on the potential utility of these risk factors, which are currently available to clinicians, in the prediction of CHD risk in asymptomatic persons. The putative mechanisms of risk, available assays, evidence for association with CHD, and the clinical implications thereof are discussed for each of the risk factors.
Similar articles
-
Novel risk factors for atherosclerosis.Mayo Clin Proc. 2000 Apr;75(4):369-80. doi: 10.4065/75.4.369. Mayo Clin Proc. 2000. PMID: 10761492 Review.
-
[Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors].MMW Fortschr Med. 2001 Jan 25;143(4):22-4. MMW Fortschr Med. 2001. PMID: 11219276 German.
-
Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.JAMA. 2003 Aug 20;290(7):932-40. doi: 10.1001/jama.290.7.932. JAMA. 2003. PMID: 12928471 Review.
-
What is the role of alternative biomarkers for coronary heart disease?Clin Endocrinol (Oxf). 2011 Sep;75(3):289-93. doi: 10.1111/j.1365-2265.2011.04045.x. Clin Endocrinol (Oxf). 2011. PMID: 21521314
-
[Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].Ital Heart J Suppl. 2001 Sep;2(9):1031-3. Ital Heart J Suppl. 2001. PMID: 11675827 Italian. No abstract available.
Cited by
-
Risk factor analysis for development of asymptomatic carotid stenosis in Koreans.J Korean Med Sci. 2006 Feb;21(1):15-9. doi: 10.3346/jkms.2006.21.1.15. J Korean Med Sci. 2006. PMID: 16479058 Free PMC article.
-
Phytoestrogen α-Zearalanol attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells.Biomed Res Int. 2013;2013:813450. doi: 10.1155/2013/813450. Epub 2013 Oct 1. Biomed Res Int. 2013. PMID: 24195080 Free PMC article. Clinical Trial.
-
Lamotrigine decreased hippocampal damage and improved vascular risk markers in a rat model of pentylenetetrazole induced kindling seizure.Korean J Physiol Pharmacol. 2014 Jun;18(3):269-78. doi: 10.4196/kjpp.2014.18.3.269. Epub 2014 Jun 12. Korean J Physiol Pharmacol. 2014. PMID: 24976768 Free PMC article.
-
Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment.Neurosciences (Riyadh). 2017 Apr;22(2):114-118. doi: 10.17712/nsj.2017.2.20160342. Neurosciences (Riyadh). 2017. PMID: 28416782 Free PMC article.
-
Comparing the effects of lovastatin and cornus MAS fruit on fibrinogen level in hypercholesterolemic rabbits.ARYA Atheroscler. 2010 Spring;6(1):1-5. ARYA Atheroscler. 2010. PMID: 22577405 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials